Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia

Status

Suspended

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00181051

Enrollment

128

Registered

2005-09-16

Start date

2003-02-28

Completion date

Unknown

Last updated

2005-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Scheduled General Anesthesia

Brief summary

Index computed in real time from Auditory Evoked Potentials have been described parallel to depth of anesthesia. The goal of the study was to compare general anesthesia guided on Auditory Evoked Potentials monitoring to standrad practice in order to assess if AEP monitoring can improve recovery delay (main criteria) or intraoperative hemodynamic stability (secondary criteria). Patients were randomized in 2 groups, stratified by center. Group I : AEP guided anesthesia, Group II: Blind AEP record, standard practice.

Interventions

DEVICEAlaris AEP monitor

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* ASA status I-II patients * aged 18 - 65 years * scheduled for general surgery (except laparoscopic interventions) lasting longer than 1 hour.

Exclusion criteria

* Body weight \< 70% or \> 150% ideal body weight * neurological disorder and hearing disorders (being not able to communicate with the patient in a normal tone) * use of any medication interfering with pharmacological effect of the study including alcohol misuse or drugs.

Design outcomes

Primary

Measure	Time frame
Influence of AEP guided anesthesia on recovery delay	—

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026